Profile
Peter A. Patriarca, M.D., is the Principal of Immuno-Vax, LLC, and a senior affiliate consultant with Biologics Consulting Group, Inc. (Alexandria, Virginia).
He has provided technical and regulatory consulting services for all phases of vaccine and other biological products development for the past 14 years for over 500 projects.
Prior to consulting, Dr. Patriarca was Corporate Head and Vice President, Worldwide Regulatory Affairs and Pharmacovigilance at MedImmune, Inc. (2001-2005) and also served as Medical Officer in the U.S.
Public Health Service at the Centers for Disease Control and Prevention (1980-1992) and the US Food and Drug Administration (1993-2001).
At FDA, Dr. Patriarca served, among other positions, as Director of the Division of Viral Products in the Office of Vaccines Research and Review (OVRR), CBER.
In that capacity, he oversaw research and review activities of more than 100 scientific staff in eight laboratories, and was intimately involved with regulatory decisions and policy affecting vaccine development and licensure.
While at CDC, Dr. Patriarca was assigned to the National Immunization Program, where, among other positions, he served as the Chief Medical Epidemiologist in the Influenza Division and the first head of CDC’s program in support of the Global Poliomyelitis Eradication Initiative.
He has authored more than 100 peer-review publications and has served on multiple scientific advisory bodies for CDC, WHO, the Bill and Melinda Gates Foundation, the American Academy of Pediatrics, the National Academy of Sciences, and numerous pharmaceutical companies.
Peter Patriarca active positions
| Companies | Position | Start |
|---|---|---|
Adjuvant Capital LP
Adjuvant Capital LP Investment ManagersFinance Adjuvant Capital invests in companies located in the United States. The firm targets companies operating in the fields of life sciences. It provides equity, mezzanine and debt financing for later stage capital requirements with an investment size of USD 10 to 25 million. | Consultant / Advisor | - |
Immuno-Vax LLC | Corporate Officer/Principal | 2018-02-28 |
Former positions of Peter Patriarca
| Companies | Position | End |
|---|---|---|
Biologics Consulting Group, Inc.
Biologics Consulting Group, Inc. Miscellaneous Commercial ServicesCommercial Services Provides regulatory and product development advice for drugs and device products | Consultant / Advisor | 2018-02-28 |
MedImmune LLC
MedImmune LLC Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Private Equity Investor | 2005-04-29 |
US Food & Drug Administration
US Food & Drug Administration General GovernmentGovernment Operates agencies to protect health and human services | Director/Board Member | 2001-07-31 |
Training of Peter Patriarca
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 6 |
|---|---|
MedImmune LLC
MedImmune LLC Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
Biologics Consulting Group, Inc.
Biologics Consulting Group, Inc. Miscellaneous Commercial ServicesCommercial Services Provides regulatory and product development advice for drugs and device products | Commercial Services |
US Food & Drug Administration
US Food & Drug Administration General GovernmentGovernment Operates agencies to protect health and human services | Government |
Tulane University School of Medicine
Tulane University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Adjuvant Capital LP
Adjuvant Capital LP Investment ManagersFinance Adjuvant Capital invests in companies located in the United States. The firm targets companies operating in the fields of life sciences. It provides equity, mezzanine and debt financing for later stage capital requirements with an investment size of USD 10 to 25 million. | Finance |
Immuno-Vax LLC |
- Stock Market
- Insiders
- Peter Patriarca
















